Shares of Nano-X Imaging Ltd. (NNOX) are gaining over 13% on Thursday morning after the medical imaging technology company announced that it has submitted 510(K) application to the U.S. Food and Drug Administration for its first version of multi-source Nanox.ARC.
NNOX is currently trading at $31.78, up $3.80 or 13.58%, on the Nasdaq.
"The 510(k) submission for the first version of our multi-source Nanox.ARC is an important achievement," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "There exists a significant unmet medical need globally for a more accessible and cost-effective medical imaging solution. If cleared by the FDA, we believe our Nanox.ARC 3-D digital tomosynthesis can address this need."
Nanox received FDA clearance of its single source Nanox Cart X-Ray System in April 2021.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.